National Lab Briefs

Exit The Fusion Critic The persistent rumors that Robert Hunter was on his way out as director of DOE’s Office of Energy Research came true last month when Hunter resigned, effective immediately. His abrupt departure marked the end of a year-long battle with advocates of magnetic-confinement fusion projects like the Princeton Plasma Lab’s tokamak. Hunter preferred a process known as inertial-confinement fusion that is being developed at Los Alamos and Lawrence Livermore national la

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The persistent rumors that Robert Hunter was on his way out as director of DOE’s Office of Energy Research came true last month when Hunter resigned, effective immediately. His abrupt departure marked the end of a year-long battle with advocates of magnetic-confinement fusion projects like the Princeton Plasma Lab’s tokamak. Hunter preferred a process known as inertial-confinement fusion that is being developed at Los Alamos and Lawrence Livermore national labs. But legislators, noting a dearth of outside support, criticized his plan. Hunter wanted to slow down magnetic fusion work and allow inertial-confinement research to “catch up” (The Scientist, Nov. 13,1989, page 9). Indeed, with politicians and magnetic-fusion scientists amassing-in opposition, even lOF program managers from the national labs shied away from endorsing Hunter’s proposal in public. The issue “is a live hand grenade I’d be stupid to touch it,” said one ICF official last month.

White House and DOE officials ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies